J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghebremedhin, B.
Right arrow Articles by Koenig, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghebremedhin, B.
Right arrow Articles by Koenig, W.
Agricola
Right arrow Articles by Ghebremedhin, B.
Right arrow Articles by Koenig, W.
J Med Microbiol 58 (2009), 678-682; DOI: 10.1099/jmm.0.005785-0
© 2009 Society for General Microbiology
ISSN 0022-2615

Case Report

Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole

B. Ghebremedhin1, A. Bluemel2, K.-H. Neumann2, B. Koenig1 and W. Koenig1

1 Clinical Microbiology, University Clinic, Magdeburg, Germany

2 Division of Nephrology, University Clinic, Magdeburg, Germany

Correspondence
B. Ghebremedhin
beniam.ghebremedhin{at}med.ovgu.de

Received August 11, 2008
Accepted January 16, 2009

Aspergillus peritonitis is a rare life-threatening complication of peritoneal dialysis (PD). We report a case of symptomatic Neosartorya pseudofischeri peritonitis in a 60-year-old woman treated by continuous ambulatory peritoneal dialysis (CAPD) for 13 months, who performed peritoneal exchanges independently. This is believed to be the first published case of N. pseudofischeri in an elderly patient. Comprehensive treatment included early removal of the PD catheter and the use of voriconazole (200 mg Vfend twice daily) for a period of 5 weeks. This case supports the need for more effective prophylaxis and treatment of non-Candida fungal infections in CAPD patients. Our conclusions from this case and a review of the literature are that infection with this fungus can cause substantial morbidity and is best treated with prompt catheter removal, aggressive antifungal therapy with voriconazole or amphotericin B, and vigilant observation for complications. Our report describes for what is believed to be the first time the administration of voriconazole to treat a Neosartorya peritonitis case.

Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; CT, computed tomography; FP, fungal peritonitis; PD, peritoneal dialysis; WCC, white cell count.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.